Haass_Melanoma_lab

Understanding the biology of melanoma heterogeneity with a goal to improve therapies. #tumor_spheroids #microscopy #scitweets #FUCCI

[Haass_Melanoma_lab @HaassLab]

Hot off the press! Congrats to Sanket, @LukeJohnsonLab and their team and collaborators - fantastic work!
Raut SB, Joly F, Haass NK, Eri R, Canales JJ, Benedek DM, Ursano RS, Johnson LR (2024). Transl Psychiatry 14: 492
doi: https://t.co/1ViVB5GGJF

[Haass_Melanoma_lab @HaassLab]

NHMRC results are out "Under Embargo". Yes we know that the Australian Government is only interested in mining and footy, but not in science and the arts. So, why Embargo?!

[Haass_Melanoma_lab @HaassLab]

Do you remember the four years (Jan 2017-Jan 2021) of chaos, destruction and disaster? Not again!
If you love democracy, unity, human rights, peace and our precious environment, please vote for Kamala Harris!

[Seth Abramson @SethAbramson]

This video is incredible.

Everyone should RETWEET it so the whole *world* sees it.

[Haass_Melanoma_lab @HaassLab]

Today!

[Melanoma and Skin Cancer Trials (MASC Trials) @MASC_Trials]

@HaassLab is a clinical scientist and academic leader at #FrazerInstUQ @UQMedicine @TRI_info. Hear his talk ‘Re-sensitisation of resistant patients to immune checkpoint therapy’ at the 2024 MASC Trials ASM, 24 October 2024, Sydney. Register: https://t.co/UlASGg3aFD
@MelanomaAus

[Translational Research Institute Australia @TRI_info]

TRI explored melanoma, the immune system, prostate, bladder and childhood brain cancer - as part of a mini-symposium today. Thanks Dr Mitchell Lawrence at @MonashUni, @srilakshmisri13, @HaassLab, Elysse Morris, Dr Liam O'Brien, @OzEDW, @BockNat. @QUT, @UQ_News, @MaterResearch.

[Haass_Melanoma_lab @HaassLab]

Long week: #FrazerInstUQ @UQMedicine HDR retreat on Monday and Tuesday on Minjerribah, and Skin Cancer 2024 conference from Wednesday through to Sunday at the BCEC! https://t.co/yZC3nEprwp

[Nature Cell Biology @NatureCellBio]

🎁Interested in reading more about the study? Here is the Research Briefing describing the authors' and an expert's view, but also the editor's perspective on the findings and their importance. #microtubule #mechanobiology
👉🏽https://t.co/eMenKJilVb
https://t.co/NN6ip7FEdx

[Haass_Melanoma_lab @HaassLab]

Great work @robertr33 et al.!
@HaassLab, #FrazerInstUQ, @UQMedicine, @TRI_info

[Nature Cell Biology @NatureCellBio]

💫NEW: @SamStehbens, @robertr33 & co show that during 3D #CellMigration, compression recruits cytoplasmic linker-associated proteins to #microtubules, which coordinate nuclear positioning and contractility in confined migration.
👉🏼https://t.co/zIlv03XDSm
https://t.co/2dROizX00c

[Haass_Melanoma_lab @HaassLab]

IUBP-MEPSA World Congress, 25th-30th August 2024, Perth.
We certainly cannot say that we didn't know better back then.

[Haass_Melanoma_lab @HaassLab]

@vivianchualah Thanks for your excellent talk, @vivianchualah

[Mitchell Stark @TheStarkLab]

Team science wins again. This project epitomises what can be achieved when the right group of people are proud together. Huge congratulations to @MelanomaACEMID team!!

[Haass_Melanoma_lab @HaassLab]

IUBP-MEPSA World Congress 2024, Perth.
Session "Melanoma heterogeneity and therapeutic approaches" on the 27th August 2024. @TheStarkLab, #FrazerInstUQ, @UQMedicine; @vivianchualah, @EdithCowanUni; Peter Lau, @PerkinsComms; @HaassLab, #FrazerInstUQ, @UQMedicine

[Haass_Melanoma_lab @HaassLab]

#FrazerInstUQ @UQMedicine HDR Minisymposium today. Great talks, great discussion. People's choice best talk award goes to Marion Barros @SimpsonTeamUQ. Runner-up was Daniel Butcher @YUmmunology. Congratulations!

[Melanoma and Skin Cancer Trials (MASC Trials) @MASC_Trials]

@HaassLab is a clinical scientist and academic leader at #FrazerInstUQ @UQMedicine @TRI_info. Hear his talk ‘Re-sensitisation of resistant patients to immune checkpoint therapy’ at the 2024 MASC Trials ASM, 24 October 2024, Sydney. Register: https://t.co/UlASGg3aFD
@MelanomaAus

[Australasian Merkel Cell Carcinoma Interest Group @AMIGOs_MASC]

@HaassLab is a clinical scientist and academic leader at #FrazerInstUQ @UQMedicine @TRI_info. Hear his talk ‘Re-sensitisation of resistant patients to immune checkpoint therapy’ at the 2024 MASC Trials ASM, 24 October 2024, Sydney. Register: https://t.co/BSg1QNF0SI
@MelanomaAus

[Ali Azimi @AliAzimi0]

Great talk by A/Prof Aideen McInerney-Leo, from UQ, about the importance of Mainstreaming Melanoma Genetic Testing in Australia. @Amcinerneyleo @AsdrResearch @CTSR_USyd

[Ali Azimi @AliAzimi0]

Prof @DrJonasANilsson, Keynote Speaker at the ASDR2024 Session 6, talking about cell therapy for therapy-resistant metastatic melanoma. @AsdrResearch @CTSR_USyd

[ASDR-Dermatology Research @AsdrResearch]

Former @AsdrResearch president Prof Nikolas Haass gave the prestigious Ross Barnetson Lecture @AsdrResearch #ASDR2024

👏👏👏👏👏👏👏👏👏👏👏👏👏

[Scott Byrne @photoimmunology]

The sun is rising over ASDR2024. It’s going to be an exciting few days here @WestmeadHub @WestmeadInst for Dermatology research @AsdrResearch. It’s all about to begin!

[Haass_Melanoma_lab @HaassLab]

Great job! Thank you so much for organising this amazing conference!

[Ali Azimi @AliAzimi0]

#ASDR2024 hardworking registration desk staff members (except me). What a great event so far! Full of talks, collaborations, sponsors, and food. @AsdrResearch @CTSR_USyd